Home › Funds › JPMorgan Chase & Co › BCLI
JPMorgan Chase & Co position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q1 2025)171 sh
Reported value held$215
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 445.70K | $1.47M | New |
| Q4 2021 | 193.17K | $773.00K | Reduce |
| Q1 2022 | 246.20K | $827.00K | Add |
| Q2 2022 | 187.07K | $516.00K | Reduce |
| Q1 2023 | 2.98K | $10.00K | New |
| Q2 2023 | 10 | $21 | Reduce |
| Q3 2023 | 39 | $8 | Add |
| Q4 2023 | 71 | $19 | Add |
| Q1 2024 | 106 | $60 | Add |
| Q2 2024 | 255 | $86 | Add |
| Q3 2024 | 175 | $40 | Reduce |
| Q4 2024 | 5 | $11 | Reduce |
| Q1 2025 | 171 | $215 | Add |
| Q1 2025 | 171 | $215 | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.